CR Group L.P.

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Houston, TX
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG...
Open signature details
/s/ Nathan D. Hukill, authorized signatory for CR Group LP, CRG Partners III LP, CRG Partners III - Parallel Fund (A) LP, CRG Partners III (Cayman) Unlev AIV I LP, CRG Partners III (Cayman) Lev AIV I LP, and CRG Partners III - Parallel Fund B (Cayman) LP
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for CR Group L.P.

Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class
Common Stock
Shares / value
4,704,729
Estimated value
$740,995
Report date
09 May 2024
Price
$0.1575
Ownership
By CRG Partners III - Parallel Fund B (Cayman) L.P.
Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class
Series A Convertible Preferred Stock
Shares / value
28,036
Estimated value
Report date
12 Apr 2024
Price
Ownership
By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Avinger Inc

Security class
Series E Convertible Preferred Stock
Shares / value
733
Estimated value
Report date
04 Aug 2023
Price
Ownership
By CRG Partners III Parallel Fund (B) (Cayman) L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Avinger Inc

Security class
Series E Convertible Preferred Stock
Shares / value
658
Estimated value
Report date
04 Aug 2023
Price
Ownership
By CRG Partners III (Cayman) Lev AIV I L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Avinger Inc

Security class
Series E Convertible Preferred Stock
Shares / value
310
Estimated value
Report date
04 Aug 2023
Price
Ownership
By CRG Partners III L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Avinger Inc

Security class
Series E Convertible Preferred Stock
Shares / value
166
Estimated value
Report date
04 Aug 2023
Price
Ownership
By CRG Partners III ? Parallel Fund (A) L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

Avinger Inc

Security class
Series E Convertible Preferred Stock
Shares / value
53
Estimated value
Report date
04 Aug 2023
Price
Ownership
By CRG Partners III (Cayman) Unlev AIV I L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class
Series A Preferred Stock
Shares / value
0
Estimated value
Report date
09 May 2024
Price
Ownership
By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding 10%+ Owner

T2 Biosystems, Inc.

Security class
Series B Preferred Stock
Shares / value
0
Estimated value
Report date
09 May 2024
Price
Ownership
By CRG Partners III - Parallel Fund B (Cayman) L.P.
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by CR Group L.P.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .